In its continued efforts to enhance Pakistan's export competitiveness by digitalizing cross-border trade processes and information requirements, the Pakistan Single Window (PSW), in collaboration with the Drug Regulatory Authority of Pakistan (DRAP), has launched the Digital Certificate of Pharmaceutical Product (COPP), required for the export of pharmaceutical products by importing countries.
In addition to COPP, the DRAP Clearance Gateway has also begun offering electronic Free Sale Certificate, Good Manufacturing Practice (GMP) Certificate, and the No Objection Certificate (NOC) for exports. This initiative aims to streamline regulatory processes, reduce delays, and align Pakistan's pharmaceutical industry with global best practices.
All certificates issued through the PSW platform are secure, electronically verifiable, and embedded with a unique QR code for instant authentication. The service eliminates inefficiencies associated with paper documentation, ensures regulatory compliance, and enhances transparency and trust in Pakistan's pharmaceutical exports, especially in highly regulated markets such as the European Union and the United States.
Exports remain a cornerstone of Pakistan's economic development, and strategic efforts like Uraan Pakistan have been rolled out to support cross-border trade. Among key sectors, the pharmaceutical industry has emerged as a high-potential contributor. In FY 2023-24, Pakistan's pharmaceutical exports reached approximately $341 million, reflecting a 3.90% growth over the previous year.
"We are proud to introduce the Digital Certificate of Pharmaceutical Product, which will bring Pakistan's pharmaceutical industry in line with global best practices," said Aftab Haider, CEO of Pakistan Single Window. "This initiative significantly enhances the efficiency and transparency of our regulatory systems and will boost exports by ensuring our products meet the highest international standards. The initiative is in line with the Prime Minister's vision of a Digital Pakistan."
Dr Obaidullah Malik, CEO of DRAP, emphasised the significance of the development, stating, "The launch of the Digital Certificate of Pharmaceutical Product (COPP), Free Sale Certificate, GMP Certificate, and Export NOC through the DRAP Clearance Gateway reflects our commitment to modernising regulatory practices and strengthening trust in Pakistan's pharmaceutical sector."
This development is a key component of Pakistan's broader strategy to digitalise regulatory systems, improve operational efficiency, and foster export-led growth in the pharmaceutical sector.
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ